
    
      Objectives:

        1. To evaluate the piperaquine and OZ439 pharmacokinetics when administered as a
           combination of piperaquine phosphate tablets with OZ439 / TPGS formulation in the fasted
           state

        2. To evaluate the piperaquine and OZ439 pharmacokinetics of a reference free combination
           formulation: piperaquine phosphate tablets with OZ439 powder in bottle (PIB) given with
           full fat milk

        3. To determine safety and tolerability of OZ439 and piperaquine phosphate when
           co-administered.
    
  